Files
2026-07-06 17:27:20 -04:00

4.0 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill INSURANCE: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols INSURANCE: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols us/states/la Louisiana Legislature 2023 HB 403 Louisiana HB 403 (2023)
bill
enacted
Chad Brown
4 20 2 2023-03-30 2023-06-06 openstates ocd-bill/9ecb7b35-d819-47e7-b7f5-46f5ed72ad39 https://www.legis.la.gov/Legis/BillInfo.aspx?i=244326 ec41248c14dfe32ae56a635c2d0c26e839cda0e686e829e452584bfad5399297 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-la

Louisiana HB 403 (2023) — INSURANCE: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. HB403 Original (filed) — source
  2. HB403 Act 125 (committee substitute) — source
  3. HB403 Engrossed (committee substitute) — source
  4. HB403 Enrolled (enrolled) — source

Votes

  • FINAL PASSAGE (#540) — 390 (pass) · upper
  • FINAL PASSAGE (#359) — 920 (pass) · lower

Sponsors

  • Chad Brown — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2023-06-06 Effective date: 08/01/2023.
  • 2023-06-06 Signed by the Governor. Becomes Act No. 125. became-law, executive-signature
  • 2023-06-01 Sent to the Governor for executive approval. executive-receipt
  • 2023-05-31 Signed by the President of the Senate.
  • 2023-05-31 Enrolled and signed by the Speaker of the House. enrolled
  • 2023-05-30 Received from the Senate without amendments. receipt
  • 2023-05-29 Rules suspended. Read by title, passed by a vote of 39 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. passage
  • 2023-05-26 Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage. reading-3
  • 2023-05-25 Read by title and referred to the Legislative Bureau.
  • 2023-05-24 Reported favorably. committee-passage-favorable
  • 2023-05-16 Read second time by title and referred to the Committee on Insurance. reading-2, referral-committee
  • 2023-05-15 Received in the Senate. Read first time by title and placed on the Calendar for a second reading. reading-1
  • 2023-05-11 Read third time by title, roll called on final passage, yeas 92, nays 0. Finally passed, title adopted, ordered to the Senate. passage
  • 2023-05-04 Scheduled for floor debate on 05/11/2023.
  • 2023-05-03 Read by title, ordered engrossed, passed to 3rd reading. reading-3
  • 2023-05-02 Reported favorably (11-0). committee-passage-favorable
  • 2023-04-10 Read by title, under the rules, referred to the Committee on Insurance. referral-committee
  • 2023-04-03 First appeared in the Interim Calendar on 4/3/2023.
  • 2023-03-30 Under the rules, provisionally referred to the Committee on Insurance. referral-committee
  • 2023-03-30 Prefiled. filing

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/9ecb7b35-d819-47e7-b7f5-46f5ed72ad39. Confidence: reported (aggregated from official Louisiana legislature records).